Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology

• Published in: Journal of Cancer Vol. 8; no. 3; pp. 479 - 489
• Main Authors: Li, Guoqing, Li, Maoyu, Liang, Xujun, Xiao, Zhefeng, Zhang, Pengfei, Shao, Meiying, Peng, Fang, Chen, Yongheng, Li, Yuanyuan, Chen, Zhuchu
• Format: Journal Article
• Language: English
• Published: Australia Ivyspring International Publisher 01.01.2017
• Subjects: Research Paper; iTRAQ; carcinogenesis; Proteomics analysis; colon cancer; DCN; HSPD1
• ISSN: 1837-9664; 1837-9664
• DOI: 10.7150/jca.17192

Colon cancer is one of the most common types of gastrointestinal cancers and the fourth cause of cancer death worldwide. To discover novel diagnostic biomarkers for colon cancer and investigate potential mechanisms of oncogenesis, quantitative proteomic approach using iTRAQ-tagging and 2D-LC-MS/MS was performed to characterize proteins alterations in colon cancer and non-neoplastic colonic mucosa (NNCM) using laser capture microdissection-harvested from the two types of tissues, respectively. As a result, 188 DEPs were identified, and the differential expression of two DEPs (DCN and HSPD1) was further verified by Western blotting and immunohistochemistry. KEGG pathway analysis disclosed that the DEPs were related to signaling pathways associated with cancer; furthermore, DCN and HSPD1 are in the relative central hub position among protein-protein interaction subnetwork of the DEPs. The results not only shed light on the mechanism by the DEPs contributed to colonic carcinogenesis, but also showed that DCN and HSPD1 are novel potential biomarkers for the diagnosis of colon cancer.